Erenumab versus topiramate for the prevention of migraine – a randomised, double-blind, active-controlled phase 4 trial

BACKGROUND: We compared the tolerability and efficacy of erenumab, a monoclonal antibody binding to the calcitonin gene-related peptide receptor, to topiramate for migraine prophylaxis in adults. METHODS: HER-MES was a 24-week, randomised, double-blind, double-dummy, controlled trial conducted in 82...

Descripción completa

Detalles Bibliográficos
Autores principales: Reuter, Uwe, Ehrlich, Marc, Gendolla, Astrid, Heinze, Axel, Klatt, Jan, Wen, Shihua, Hours-Zesiger, Peggy, Nickisch, Jacqueline, Sieder, Christian, Hentschke, Christian, Maier-Peuschel, Monika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793299/
https://www.ncbi.nlm.nih.gov/pubmed/34743579
http://dx.doi.org/10.1177/03331024211053571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793299/
https://www.ncbi.nlm.nih.gov/pubmed/34743579
http://dx.doi.org/10.1177/03331024211053571

Ejemplares similares